Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Flavin mononucleotide (FMN) riboswitch is a highly conserved regulatory RNA element located in the 5' untranslated region of bacterial mRNAs, primarily those involved in riboflavin (vitamin B2) biosynthesis and transport (Serganov et al., Nature, 2009). It functions as a metabolite-sensing genetic switch that directly binds FMN with high affinity, triggering a conformational change that modulates gene expression through Rho-independent transcription termination or inhibition of translation initiation (Winkler et al., PNAS, 2002). This riboswitch is essential for maintaining riboflavin homeostasis in many pathogenic bacteria, including Staphylococcus aureus and Bacillus subtilis, making it a critical survival factor (Howe et al., Nature, 2015). Because riboswitches are prevalent in bacteria but absent in the human genome, they represent a promising class of targets for the development of novel, highly specific antibacterial agents (Blount & Breaker, Nature Biotechnology, 2006). Small molecules like Ribocil and its derivatives have been identified as potent inhibitors that mimic FMN, binding to the riboswitch to repress essential metabolic pathways and effectively halt bacterial growth (Vicens et al., Frontiers in Genetics, 2018).
Ligand-induced conformational change in the RNA aptamer domain that triggers premature transcription termination or prevents translation initiation of downstream genes.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Flavin mononucleotide riboswitch (FMN riboswitch) (FMN riboswitch).